title: Variability in Diagnosis and Treatment of Ventilator-Associated Pneumonia in Neurocritical Care Patients.
abstract: BACKGROUND
  Clinical approach to ventilator-associated pneumonia (VAP) in the neurocritical care unit (NCCU) varies widely among physicians despite training and validated criteria.
  
  
  METHODS
  Prospective observational study of all mechanically ventilated patients with suspected VAP over 18 months in an academic NCCU. Patients meeting VAP criteria by a surveillance program (SurvVAP) were compared to treated patients who did not meet surveillance criteria (ClinVAPonly). We identified appropriate/potentially inappropriate antibiotic treatment and factors associated with excessive antibiotic days (EAD).
  
  
  RESULTS
  Of 622 ventilated patients, 83 cases were treated as VAP. Of these, 26 (31.3 %) had VAP by CDC criteria (SurvVAP) (VAP rate = 7.3 cases/1,000 ventilator days). Clinical features significantly more prevalent in SurvVAP cases (vs. ClinVAPonly) were change in sputum character, tachypnea, oxygen desaturation, persistent infiltrate on chest X-ray and higher clinical pulmonary infection score, but not positive sputum culture. Treatment with pneumonia-targeted antibiotics for >8 days was significantly more common in ClinVAPonly versus SurvVAP patients (73.7 vs. 30.8 %, p < 0.001) even after excluding patients with other infections (p = 0.001). Based on current guidelines, the ClinVAPonly group contributed 225 EAD, including 38 vancomycin days, 70 piperacillin-tazobactam days and 85 cephalosporin days with cost figure over four times that of EAD in SurvVAP group. No pre-specified factors were associated with continued VAP treatment beyond 8 days.
  
  
  CONCLUSIONS
  Incongruency between clinically and surveillance-defined VAP is common in acute neurological disease although outcomes did not differ between groups. Clinician behaviors rather than clinical factors may contribute to prolonged prescribing.
authors: Division of Neurosciences Critical Care, Departments of Neurology, Anesthesiology and Critical Care Medicine, The Johns Hopkins Hospital, Johns Hopkins University School of Medicine, 600 N. Wolfe Street/Phipps 413, Baltimore, MD, 21287, USA.
authors: Atul A
authors: AA
authors: Kalanuria
authors: Donna
authors: D
authors: Fellerman
authors: Paul
authors: P
authors: Nyquist
authors: Romergryko
authors: R
authors: Geocadin
authors: Robert G
authors: RG
authors: Kowalski
authors: Veronique
authors: V
authors: Nussenblatt
authors: Matthew
authors: M
authors: Rajarathinam
authors: Wendy
authors: W
authors: Ziai
mesh_terms: D000890:Anti-Infective Agents / Q000627:therapeutic use*; D003422:Critical Care / Q000706:statistics & numerical data*; D005260:Female; D006801:Humans; D007362:Intensive Care Units / Q000706:statistics & numerical data*; D008297:Male; D008875:Middle Aged; D009422:Nervous System Diseases / Q000453:epidemiology* / Q000628:therapy; D053717:Pneumonia, Ventilator-Associated / Q000188:drug therapy / Q000453:epidemiology*; D011446:Prospective Studies
chemical_list: D000890:Anti-Infective Agents
references: BMJ. 2012 May 29;344:e3325
references: 22645207
references: Am J Infect Control. 2010 Apr;38(3):237-9
references: 20171757
references: Am J Respir Crit Care Med. 1998 Feb;157(2):531-9
references: 9476869
references: Chest. 1997 Mar;111(3):676-85
references: 9118708
references: Clin Microbiol Rev. 2006 Oct;19(4):637-57
references: 17041138
references: Neurocrit Care. 2012 Feb;16(1):123-9
references: 21674278
references: Am J Respir Crit Care Med. 2000 Aug;162(2 Pt 1):505-11
references: 10934078
references: JAMA. 2003 Nov 19;290(19):2588-98
references: 14625336
references: J Crit Care. 2012 Oct;27(5):527.e7-11
references: 22227077
references: Infect Control Hosp Epidemiol. 2014 Mar;35(3):278-84
references: 24521594
references: Clin Infect Dis. 2009 Aug 15;49 Suppl 1:S36-43
references: 19619020
references: Respir Care. 2005 Jul;50(7):932-52; discussion 952-5
references: 15972114
references: Expert Rev Anti Infect Ther. 2012 Jan;10(1):63-73
references: 22149615
references: Chest. 1993 Feb;103(2):547-53
references: 8432152
references: JAMA. 2007 Apr 11;297(14):1583-93
references: 17426278
references: JAMA. 1995 Aug 23-30;274(8):639-44
references: 7637145
references: Chest. 1992 Feb;101(2):458-63
references: 1735272
references: Clin Infect Dis. 2010 Aug 1;51 Suppl 1:S42-7
references: 20597671
references: Chest. 2002 Dec;122(6):2115-21
references: 12475855
references: Scand J Infect Dis. 1999;31(3):299-303
references: 10482061
references: Am J Infect Control. 2013 Dec;41(12):1148-66
references: 24274911
references: Crit Care Clin. 2011 Jan;27(1):149-62
references: 21144991
references: Am J Infect Control. 2008 Jun;36(5):309-32
references: 18538699
references: Crit Care Med. 2005 Jan;33(1):46-53
references: 15644647
references: Chest. 1993 Oct;104(4):1230-5
references: 8404198